Moods Disorders Completed Phase 2 Trials for Erythropoietin (DB00016)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00916552Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar DisorderTreatment